ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
113.55
-0.98 (-0.86%)
At close: May 18, 2026, 4:00 PM EDT
113.29
-0.26 (-0.23%)
Pre-market: May 19, 2026, 5:50 AM EDT
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of $8.87 billion as of May 19, 2026. Its market cap has increased by 1,883.57% in one year.
Market Cap
8.87B
Enterprise Value
8.29B
1-Year Change
1,883.57%
Ranking
Category
Stock Price
$113.55
Market Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from $225.47M to $8.87B, an increase of 3,832.81%. That is a compound annual growth rate of 40.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 8.87B | -19.41% |
| Dec 31, 2025 | 11.00B | 2,382.10% |
| Dec 31, 2024 | 443.27M | -34.81% |
| Dec 29, 2023 | 679.99M | 513.79% |
| Dec 30, 2022 | 110.78M | -79.15% |
| Dec 31, 2021 | 531.29M | -8.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Madrigal Pharmaceuticals | 12.07B |
| Axsome Therapeutics | 11.72B |
| Arrowhead Pharmaceuticals | 10.80B |
| Cytokinetics | 10.30B |
| BioMarin Pharmaceutical | 10.01B |
| Praxis Precision Medicines | 9.55B |
| Krystal Biotech | 9.03B |
| ImmunityBio | 8.35B |